<DOC>
	<DOC>NCT01746901</DOC>
	<brief_summary>The main purpose of this study is to determine if oxycodone and naltrexone combination capsules (ALO-02) have the potential to be abused.</brief_summary>
	<brief_title>A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Abusers</brief_title>
	<detailed_description>Abuse Liability Study</detailed_description>
	<mesh_term>Analgesics, Opioid</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Healthy subjects. Nondependent, recreational opioid users. (Must use opioid for nontherapeutic purposes on at least 10 occassions within the last year before Screening Visit, and at least once in 8 weeks before the Screening Visit. Diagnosis of substance and/or alcohol dependence. Subject has participated in, is currently participating in, or is seeking treatment for substance and/or alcohol related disorder. History of sleep apnea. Positive urine drug screen (UDS) for other that marijuana. Positive for Hepatitis B or C and HIV on Screening.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Relative abuse potential study; oxycodone; nalteone; Opioid-related disorders; drug abusers</keyword>
	<keyword>Chronic pain</keyword>
</DOC>